Medirom Healthcare Reports September 2024 KPIs
Ticker: MRM · Form: 6-K · Filed: Oct 24, 2024 · CIK: 1819704
Sentiment: neutral
Topics: kpi-update, press-release, foreign-private-issuer
TL;DR
Medirom Healthcare dropped its Sept 2024 KPIs today via 6-K.
AI Summary
Medirom Healthcare Technologies Inc. announced on October 24, 2024, its updated Key Performance Indicators (KPIs) for September 2024. The company is providing this information via a press release furnished as part of this Form 6-K filing.
Why It Matters
This filing provides investors with updated operational metrics for Medirom Healthcare Technologies Inc., allowing for a timely assessment of the company's recent performance.
Risk Assessment
Risk Level: low — This is a routine filing providing updated operational data, not announcing significant financial events or changes.
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Filer of the report
- October 24, 2024 (date) — Date of press release issuance
- September 2024 (date) — Period for which KPIs are updated
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report the issuance of a press release by Medirom Healthcare Technologies Inc. announcing its updated Key Performance Indicators (KPIs) for September 2024.
When was the press release announcing the KPIs issued?
The press release was issued on October 24, 2024.
What period do the updated KPIs cover?
The updated KPIs cover the month of September 2024.
Is the press release considered 'filed' for Section 18 purposes?
No, the press release furnished in this report as Exhibit 99.1 shall not be deemed to be 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934.
What is the company's principal executive office address?
The company's principal executive office is located at 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.
Filing Stats: 272 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2024-10-24 06:02:16
Filing Documents
- tmb-20241024x6k.htm (6-K) — 15KB
- tmb-20241024xex99d1.htm (EX-99.1) — 99KB
- tmb-20241024xex99d1001.jpg (GRAPHIC) — 4KB
- tmb-20241024xex99d1004.jpg (GRAPHIC) — 28KB
- tmb-20241024xex99d1005.jpg (GRAPHIC) — 33KB
- tmb-20241024xex99d1006.jpg (GRAPHIC) — 30KB
- tmb-20241024xex99d1007.jpg (GRAPHIC) — 24KB
- tmb-20241024xex99d1009.jpg (GRAPHIC) — 50KB
- tmb-20241024xex99d1012.jpg (GRAPHIC) — 54KB
- tmb-20241024xex99d1013.jpg (GRAPHIC) — 53KB
- 0001558370-24-013556.txt ( ) — 497KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDIROM HEALTHCARE TECHNOLOGIES INC. Date: October 24, 2024 By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer